{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:05:18Z","timestamp":1777421118954,"version":"3.51.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Drug use disorders (DUDs), a significant public health issue worldwide, encompass disorders related to sedatives, cannabis, opioids, heroin, hallucinogens, club drugs, and inhalants. This study examines the changes in the global burden of DUDs from 1990 to 2021, aiming to provide a scientific foundation for strategies to mitigate the harms associated with substance abuse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study utilized Global Burden of Disease (GBD) 2021 data to analyze trends in the incidence, prevalence, mortality, disability-adjusted life years (DALYs) associated with DUDs through Socio-demographic Index (SDI), attributable risk factors, and EAPC. Decomposition analysis was employed to assess the impact of age, gender, and SDI on the burden of DUDs, while the inequality distribution of DALYs was examined using the inequality slope index (SII) and the concentration index (CI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Opioid use disorder accounted for the highest age-standardized disability rates (ASDR) and age-standardized mortality rates (ASMR) among the five drug use disorders, while cannabis use disorder is the leading cause of Age-standardized prevalence rates (ASPR). The Age-standardized incidence rates (ASIR) of opioid use disorder has demonstrated a downward trend, whereas both ASPR and ASMR have shown an increase; notably, the ASIR for opioid use disorder has declined the least among the five drug use disorders. The burden of DUDs in high SDI areas is significantly greater than that in low SDI areas, with income inequality exacerbating the uneven distribution of DALYs. The primary attributable risk factors are drug use and behavioral risks. While the ASIR of opioid use disorder is increasing, while others are experiencing a decline. The burden of DUDs varies among the five drug use disorders due to factors such as population aging, population changes, and age distribution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings reveal absolute and relative inequalities in DALYs associated with drug use disorders, which are concentrated in high-income regions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1588607","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:37:35Z","timestamp":1761025055000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Global, regional and national burden of drug use disorders, 1990\u20132021: decomposition analysis, health inequality analysis and predictions to 2035"],"prefix":"10.3389","volume":"13","author":[{"given":"Ruiying","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baixi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"109542","DOI":"10.1016\/j.drugalcdep.2022.109542","article-title":"Time trends and associated factors of global burden due to drug use disorders in 204 countries and territories, 1990-2019","volume":"238","author":"Chen","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1176\/appi.ajp.160.5.890","article-title":"The role of psychiatric disorders in predicting drug dependence treatment outcomes","volume":"160","author":"Compton","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref3","year":""},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1186\/s12889-024-19142-0","article-title":"Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Public Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of DSM-5 Drug use disorder: results from the National Epidemiologic Survey on Alcohol and related conditions-III","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref6","year":"2024"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1017\/S2045796020000657","article-title":"Trends of the incidence of drug use disorders from 1990 to 2017: an analysis based on the global burden of disease 2017 data","volume":"29","author":"Pan","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1470809","DOI":"10.3389\/fpubh.2024.1470809","article-title":"Global burden of drug use disorders by region and country, 1990-2021","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref11","year":""},{"key":"ref12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.chest.2023.09.028","article-title":"Disease burden and prediction analysis of tracheal, bronchus, and lung Cancer attributable to residential radon, solid fuels, and particulate matter pollution under different sociodemographic transitions from 1990 to 2030","volume":"165","author":"Liu","year":"2024","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil Med Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12963-024-00357-7","article-title":"The global burden of disease study and population health metrics","volume":"22","author":"Wyper","year":"2024","journal-title":"Popul Health Metrics"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-024-01798-z","article-title":"Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the global burden of disease study 2021","volume":"25","author":"Cen","year":"2024","journal-title":"J Headache Pain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/JS9.0000000000001902","article-title":"The global, regional, and national patterns of change in the burden of non-malignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade","volume":"111","author":"Bai","year":"2024","journal-title":"Int J Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106250","DOI":"10.1016\/j.jinf.2024.106250","article-title":"Global temporal trends and projections of acute hepatitis E incidence among women of childbearing age: age-period-cohort analysis 2021","volume":"89","author":"Huang","year":"2024","journal-title":"J Infect"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e0216613","DOI":"10.1371\/journal.pone.0216613","article-title":"A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate","volume":"14","author":"Cheng","year":"2019","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102791","DOI":"10.1016\/j.dsx.2023.102791","article-title":"The impact of global, regional, and national population ageing on disability-adjusted life years and deaths associated with diabetes during 1990-2019: a global decomposition analysis","volume":"17","author":"Zhang","year":"2023","journal-title":"Diabetes Metab Syndr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e1003138","DOI":"10.1371\/journal.pmed.1003138","article-title":"Population ageing and mortality during 1990-2017: a global decomposition analysis","volume":"17","author":"Cheng","year":"2020","journal-title":"PLoS Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.arr.2023.102124","article-title":"Global, regional, and national prevalence of hearing loss from 1990 to 2019: a trend and health inequality analyses based on the global burden of disease study 2019","volume":"92","author":"Jiang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103674","DOI":"10.1016\/j.autrev.2024.103674","article-title":"Global burden due to modifiable risk factors for autoimmune diseases, 1990-2021: temporal trends and socio-demographic inequalities","volume":"23","author":"Guan","year":"2024","journal-title":"Autoimmun Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"108476","DOI":"10.1016\/j.neuropharm.2021.108476","article-title":"Factors mediating pain-related risk for opioid use disorder","volume":"186","author":"Nazarian","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable Mendelian randomization analysis","volume":"78","author":"Rosoff","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1176\/appi.ajp.20220713","article-title":"Opioid use disorder, Cannabis use disorder, and a mindfulness intervention affecting pain-related neural substrates","volume":"179","author":"Kalin","year":"2022","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-pharmtox-010617-052534","article-title":"The opioid epidemic: crisis and solutions","volume":"58","author":"Skolnick","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jama.2025.0240","article-title":"US ranks highest in global overdose deaths","volume":"333","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"5","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.drugalcdep.2016.08.625","article-title":"Remission from substance use disorders: a systematic review and meta-analysis","volume":"168","author":"Fleury","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.18502\/ijps.v15i2.2691","article-title":"Addiction recovery: a systematized review","volume":"15","author":"Inanlou","year":"2020","journal-title":"Iran J Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/14622200701243193","article-title":"Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers","volume":"9","author":"Berlin","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1111\/add.15396","article-title":"Sex differences in factors predicting post-treatment opioid use","volume":"116","author":"Davis","year":"2021","journal-title":"Addiction"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","article-title":"Sex and gender differences in substance use disorders","volume":"66","author":"McHugh","year":"2018","journal-title":"Clin Psychol Rev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/BF02246017","article-title":"Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers","volume":"125","author":"Lukas","year":"1996","journal-title":"Psychopharmacology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.pop.2020.02.013","article-title":"Adolescent substance abuse","volume":"47","author":"Garofoli","year":"2020","journal-title":"Prim Care"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S2215-0366(16)00002-X","article-title":"Prevention, early intervention, harm reduction, and treatment of substance use in young people","volume":"3","author":"Stockings","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"107639","DOI":"10.1016\/j.amepre.2025.04.009","article-title":"Family-based interventions to prevent substance use among youth: community guide systematic economic review","volume":"69","author":"Jacob","year":"2025","journal-title":"Am J Prev Med"},{"key":"ref39","volume-title":"World drug report","year":"2020"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.mayocp.2020.10.011","article-title":"Substance use disorders and telehealth in the COVID-19 pandemic era: a new outlook","volume":"95","author":"Oesterle","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"108766","DOI":"10.1016\/j.neuropharm.2021.108766","article-title":"Covid-19 interface with drug misuse and substance use disorders","volume":"198","author":"Cisneros","year":"2021","journal-title":"Neuropharmacology"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1588607\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:37:36Z","timestamp":1761025056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1588607\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2025.1588607"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1588607","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1588607"}}